RxDoctor Payments Data

Katlin O'Hara

Primary Podiatric Medicine · Lancaster, SCNPI 1437503422

Payments from drug & device makers

What this record shows

27 manufacturers reported payments, led by Triad Life Sciences Inc. at 57.3% of the total. Reporting peaked in 2022 at $3,502 and has fallen 93.8% since, to $219 in 2025.

$5,786in general payments, 2019–2025

Across 104 payments — averaging $55.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Triad Life Sciences Inc.$3K
  • Convatec Inc.$386
  • Organogenesis Inc.$330
  • Smith+Nephew$271
  • Amgen$196
  • Zimmer Biomet$171
  • plus $1K from 21 others

What the payments were for

  • Travel & lodging$2,39241%
  • Food & beverage$3,39459%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few primary podiatric medicine providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$288,406
Medicare patients
760
Services billed
3,384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole36$1,940
Cephalexin26$337
Ammonium Lactate13$336
Colchicine13$324
Terbinafine Hcl21$254
Ibuprofen28$187
Methylprednisolone26$169
Tobramycin31$155
Doxycycline Hyclate22$146

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Lancaster

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →